Literature DB >> 35496965

Acute Promyelocytic Leukemia with Hyperleukocytosis: Improving Outcomes with Current Therapy.

Tejasvini Vaid1, Mukul Aggarwal1, Akriti Khare1, Ganesh Kumar Viswanathan1, Jasmita Dass1, Pradeep Kumar1, Rishi Dhawan1, Tulika Seth1, Seema Tyagi1, Manoranjan Mahapatra1.   

Abstract

Entities:  

Year:  2022        PMID: 35496965      PMCID: PMC9001788          DOI: 10.1007/s12288-021-01509-7

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


× No keyword cloud information.
  4 in total

1.  Clinical characteristics and outcomes in patients with acute promyelocytic leukaemia and hyperleucocytosis.

Authors:  Naval Daver; Hagop Kantarjian; Guido Marcucci; Sherry Pierce; Mark Brandt; Courtney Dinardo; Naveen Pemmaraju; Guillermo Garcia-Manero; Susan O'Brien; Alessandra Ferrajoli; Srdan Verstovsek; Uday Popat; Chitra Hosing; Paolo Anderlini; Gautam Borthakur; Tapan Kadia; Jorge Cortes; Farhad Ravandi
Journal:  Br J Haematol       Date:  2014-10-14       Impact factor: 6.998

2.  All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4).

Authors:  Harry J Iland; Ken Bradstock; Shane G Supple; Alberto Catalano; Marnie Collins; Mark Hertzberg; Peter Browett; Andrew Grigg; Frank Firkin; Amanda Hugman; John Reynolds; Juliana Di Iulio; Campbell Tiley; Kerry Taylor; Robin Filshie; Michael Seldon; John Taper; Jeff Szer; John Moore; John Bashford; John F Seymour
Journal:  Blood       Date:  2012-06-19       Impact factor: 22.113

3.  Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.

Authors:  M A Sanz; F Lo Coco; G Martín; G Avvisati; C Rayón; T Barbui; J Díaz-Mediavilla; G Fioritoni; J D González; V Liso; J Esteve; F Ferrara; P Bolufer; C Bernasconi; M Gonzalez; F Rodeghiero; D Colomer; M C Petti; J M Ribera; F Mandelli
Journal:  Blood       Date:  2000-08-15       Impact factor: 22.113

4.  Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.

Authors:  Francesco Lo-Coco; Giuseppe Avvisati; Marco Vignetti; Christian Thiede; Sonia Maria Orlando; Simona Iacobelli; Felicetto Ferrara; Paola Fazi; Laura Cicconi; Eros Di Bona; Giorgina Specchia; Simona Sica; Mariadomenica Divona; Alessandro Levis; Walter Fiedler; Elisa Cerqui; Massimo Breccia; Giuseppe Fioritoni; Helmut R Salih; Mario Cazzola; Lorella Melillo; Angelo M Carella; Christian H Brandts; Enrica Morra; Marie von Lilienfeld-Toal; Bernd Hertenstein; Mohammed Wattad; Michael Lübbert; Matthias Hänel; Norbert Schmitz; Hartmut Link; Maria Grazia Kropp; Alessandro Rambaldi; Giorgio La Nasa; Mario Luppi; Fabio Ciceri; Olimpia Finizio; Adriano Venditti; Francesco Fabbiano; Konstanze Döhner; Michaela Sauer; Arnold Ganser; Sergio Amadori; Franco Mandelli; Hartmut Döhner; Gerhard Ehninger; Richard F Schlenk; Uwe Platzbecker
Journal:  N Engl J Med       Date:  2013-07-11       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.